- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01776983
Skin Aging in Renal Transplant Patients
June 15, 2015 updated by: University of Zurich
Determination of collagen, pigment and haemoglobin content of sun exposed and sun protected skin by Siascopy. Immunocompromised patients (for more than seven years) compared to immunocompetent patients.
- Trial in the field of transplantation / xenotransplantation
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Determination of collagen, pigment and haemoglobin content of sun exposed and sun protected skin by Siascopy.
Immunocompromised patients (for more than seven years) compared to immunocompetent patients.
Study Type
Observational
Enrollment (Actual)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
ZH
-
Zurich, ZH, Switzerland, 8091
- University Hospital Zurich, Department of Dermatology
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
individuals between 18 and 90 years of age
Description
Inclusion criteria:
- Renal transplant recipients transplanted more than seven years ago and immunocompetent probands of the same age.
Exclusion criteria:
- Refusal of informed consent, physical or psychological inability to give informed consent.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
skin aging defined by melanin, collagen and hemoglobin content
Time Frame: One Time measurement at the one and only time point of inclusion and measurement
|
there is only one time point for measurement, there is no "time frame", just one single measurement per patient at the one and only visit
|
One Time measurement at the one and only time point of inclusion and measurement
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Günther Hofbauer, MD, University Hospital Zurich, Department of Dermatology
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2008
Primary Completion (Actual)
November 1, 2013
Study Completion (Actual)
January 1, 2014
Study Registration Dates
First Submitted
January 24, 2013
First Submitted That Met QC Criteria
January 24, 2013
First Posted (Estimate)
January 28, 2013
Study Record Updates
Last Update Posted (Estimate)
June 16, 2015
Last Update Submitted That Met QC Criteria
June 15, 2015
Last Verified
June 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2008SIA01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Photosensitivity Disorders
-
Universität des SaarlandesCompleted
-
Johnson & Johnson Vision Care, Inc.CompletedPhotosensitivityUnited States
-
Wright State UniversityRecruitingPhotosensitivity | Microvesicle ParticleUnited States
-
University of PennsylvaniaCompletedLupus Erythematosus | Photosensitivity ConditionsUnited States
-
Nanometics (d.b.a. PHD Biosciences)Completed
-
DSM Nutritional Products, Inc.CompletedSunburnUnited States
-
Mantecorp Industria Quimica e Farmaceutica Ltd.Unknown
-
Mantecorp Industria Quimica e Farmaceutica Ltd.Unknown
-
Bispebjerg HospitalUnknown
-
Sephoris Pharmaceuticals LLCTerminated
Clinical Trials on Photosensitivity under the influence of immunocomp
-
University of BernETH Zurich; University of St.GallenCompletedAlcohol Drinking | Impaired Driving | Drunk DrivingSwitzerland
-
Iacob Czihac Emergency Military Clinical HospitalCompleted
-
University of BernETH Zurich; University of St.GallenCompletedAlcohol Drinking | Impaired Driving | Transportation Accidents | Drunk DrivingSwitzerland
-
Assistance Publique Hopitaux De MarseilleRecruitingCancer and / or Hematological MalignancyFrance
-
Hospices Civils de LyonCompleted
-
NDR Medical Technology Pte LtdUniversity of MalayaCompleted
-
Ospedale di Circolo - Fondazione MacchiCompletedInfant Conditions | Infant Behavior | Infant MorbidityItaly
-
Seoul National University HospitalTerminatedBispectral Index, Monitored Anesthesia CareKorea, Republic of
-
Centre Leon BerardCentre de Recherche en Cancérologie de LyonCompletedBreast Cancer | MetastasisFrance
-
AHS Cancer Control AlbertaCross Cancer InstituteCompleted